他汀类药物用于成人首次发生静脉血栓栓塞性疾病。
完整摘要 · 中文译文
这是一项Cochrane系统评价（干预性）的方案。目标如下：评估他汀类药物在复发性静脉血栓栓塞性疾病（RVTE）二级预防中的获益与危害：深静脉血栓形成（DVT）、肺血栓栓塞（PTE）及血栓后综合征（PTS），针对首次发生深静脉血栓的患者。次要目标：评估他汀类药物在伴有或不伴有癌症、不同性别以及70岁以上普通人群中，RVTE、DVT、PTE及PTS二级预防中的获益与危害。
完整摘要 · 英文原文
This is a protocol for a Cochrane review (intervention). The objectives are as follows: To evaluate the benefits and harms of statins in the secondary prevention of Recurrent Venous ThromboEmbolic disease (RVTE): Deep Vein Thrombosis (DVT), Pulmonary ThromboEmbolism (PTE) and Post-Thrombotic Syndrome (PTS) in patients with a first episode of deep vein thrombosis Secondary objective To evaluate the benefits and harms of statins in the secondary prevention of RVTE, DVT, PTE and PTS in patients with or without cancer, in different sexes and in the general population aged over 70 years.